Evidence map›Paper›PMID 25319508›Full record

ArticleJournal of applied microbiology2015

Oral lactoferrin protects against experimental candidiasis in mice.

K Velliyagounder, W Alsaedi, W Alabdulmohsen, K Markowitz, D H Fine

Open access · greenAbstract read
In one paragraph

Article in Journal of applied microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Promising Anti-Biofilm Agents and Phagocytes Enhancers for the Treatment ofFrontiers in cellular and infection microbiology · 2022
    Article
  3. Article
  4. Iron Chelator Deferasirox ReducesAntimicrobial agents and chemotherapy · 2019
    Article
  5. Iron at the Centre ofFrontiers in cellular and infection microbiology · 2018
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K VelliyagounderRUTGERS School of Dental Medicine, Newark, NJ, USA.
W Alsaedi
W Alabdulmohsen
K Markowitz
D H Fine
Rutgers, The State University of New Jersey · US

Funding

Functions of Lactoferrin Polymorphisms in an Oral InfectionR21DE019548 · NIDCR · UNIV OF MED/DENT OF NJ-NJ DENTAL SCHOOL · PI VELLIYAGOUNDER, KABILAN · 2010 to 2011
$427k
NIDCR NIH HHS R21 DE019548
6 · The paper itself

Abstract

aimsTo determine the role of human lactoferrin (hLF) in protecting the oral cavities of mice against Candida albicans infection in lactoferrin knockout (LFKO(-/-)) mice was compared to wild-type (WT) mice. We also aim to determine the protective role of hLF in LFKO(-/-) mice. METHODS AND

resultsAntibiotic-treated immunosuppressed mice were inoculated with C. albicans (or sham infection) by oral swab and evaluated for the severity of infection after 7 days of infection. To determine the protective role of hLF, we added 0·3% solution of hLF to the drinking water given to some of the mice. CFU count, scoring of lesions and microscopic observations were carried out to determine the severity of infection. LFKO(-/-) I mice showed a 2 log (P = 0·001) higher CFUs of C. albicans in the oral cavity compared to the WT mice infected with C. albicans (WTI). LFKO(-/-) I mice given hLF had a 3 log (P = 0·001) reduction in CFUs in the oral cavity compared to untreated LFKO(-/-) I mice. The severity of infection, observed by light microscopy, revealed that the tongue of the LFKO(-/-) I mice showed more white patches compared to WTI and LFKO(-/-) I + hLF mice. Scanning electron microscopic observations revealed that more filiform papillae were destroyed in LFKO(-/-) I mice when compared to WTI or LFKO(-/-) I + hLF mice.

conclusionsHuman LF is important in protecting mice from oral C. albicans infection. Administered hLF may be used to prevent C. albicans infection. SIGNIFICANCE AND IMPACT OF THE STUDY: Human LF, a multifunctional iron-binding glycoprotein can be used as a therapeutic active ingredient in oral healthcare products against C. albicans.

Indexed as

Administration, OralAnimalsAnti-Bacterial AgentsCandida albicansCandidiasisHumansLactoferrinMaleMiceMice, KnockoutMouth DiseasesTongueAnti-Bacterial AgentsLactoferrinLTF protein, humanLtf protein, mouseCandida albicansexperimental candidiasishuman lactoferrinlactoferrin knockoutoral candidiasis

Identifiers

PMID25319508
PMCPMC4469205
OpenAlexW2035860800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.